Literature DB >> 21493692

PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature.

S Liu1, K Wah Chan, J Tong, Y Wang, B Wang, L Qiao.   

Abstract

We report a case of liver cancer with features consistent with fibrolamellar hepatocellular carcinoma (FLHCC) detected by PET-CT scan. A 20-year-old female with a large liver tumor was diagnosed with 'malignant hepatic tumor' 2 years earlier and received five courses of transhepatic arterial chemoembolization (TACE) before she presented to our hospital with abdominal distension and mild pain at the right upper quadrant. Ultrasound and CT scan showed a large tumor in the right lobe of the liver. Contrast CT scan and (18)F-FDG PET-CT showed metastatic lesions in multiple organs. The imaging diagnosis was confirmed by an ultrasound-guided fine needle biopsy of the hepatic lesion which showed features of FLHCC. Immunohistochemical staining showed a marked increase in the expressions of Hepar, CD99, MIB1, proliferating cell nuclear antigen (PCNA), Fibronectin, E-cadherin and CK7. The recent knowledge on the FLHCC and the possible applications of PET-CT were discussed.
© The Author 2011. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493692     DOI: 10.1093/qjmed/hcr040

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  7 in total

1.  Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database.

Authors:  Georgios Polychronidis; Jincheng Feng; Anastasia Murtha-Lemekhova; Ulrike Heger; Arianeb Mehrabi; Katrin Hoffmann
Journal:  Int J Gen Med       Date:  2022-01-08

Review 2.  Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.

Authors:  Walaa Abdelhamed; Mohamed El-Kassas
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

Review 3.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

4.  Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2015-12-30

Review 5.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09

6.  Differential Diagnosis of Hepatic Mass with Central Scar: Focal Nodular Hyperplasia Mimicking Fibrolamellar Hepatocellular Carcinoma.

Authors:  Teodoro Rudolphi-Solero; Eva María Triviño-Ibáñez; Antonio Medina-Benítez; Javier Fernández-Fernández; Daniel José Rivas-Navas; Alejandro José Pérez-Alonso; Manuel Gómez-Río; Tarik Aroui-Luquin; Antonio Rodríguez-Fernández
Journal:  Diagnostics (Basel)       Date:  2021-12-27

Review 7.  Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers.

Authors:  Lorenzo Mulazzani; Margherita Alvisi
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.